Our understanding of acute lymphoblastic leukemia (ALL) has expanded tremendously in
the past few years because of large-scale genomic studies. 1, 2 ALL is characterized by a …

Peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) is a diagnosis of
exclusion, being the most common entity in mature T-cell neoplasms, and its molecular …

The novel genetic information gained from genome-wide high throughput techniques has
greatly improved our understanding of peripheral T-cell lymphoma (PTCL). PTCL consists of …

T-cell lymphoblastic lymphoma (T-LBL) and lymphoblastic leukemia (T-ALL) represent
malignancies that arise from the transformation of immature precursor T cells. Similarities in …

Adult T-cell leukemia/lymphoma (ATLL) is the neoplasm caused by human T-cell leukemia
virus type 1 (HTLV-1). We performed oligo-array comparative genomic hybridization (CGH) …

The molecular hallmarks of adult T cell leukemia (ATL) comprise outstanding deregulations
of signaling pathways that control the cell cycle, resistance to apoptosis, and proliferation of …

T-cell acute lymphoblastic leukemia (T-ALL) is a challenging clinical entity with high rates of
induction failure and relapse. To discover the genetic changes occurring in T-ALL, and those …

T‐cell acute lymphoblastic leukemia (T‐ALL) and lymphoma (T‐LBL) share common
morphological and immunophenotypic features and are treated with similar therapeutic …

Recent developments in genomic technologies have resulted in increased understanding of
pathogenic mechanisms and emphasized the importance of central survival pathways. Here …

Adult T-cell leukemia/lymphoma (ATLL) is a distinct form of peripheral T-cell lymphoma with
poor prognosis, which is caused by the human T-lymphotropic virus type 1 (HTLV-1). In …